Neuberger Berman Group
ADPT icon

Neuberger Berman Group’s Adaptive Biotechnologies ADPT Stock Holding History

Neuberger Berman Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
110,664
-340,905
-75% -$5.43M ﹤0.01% 1264
2025
Q4 		$7.33M Buy
451,569
+348,445
+338% +$5.69M 0.01% 886
2025
Q3 		$1.54M Buy
103,124
+1,082
+1% +$13.2K ﹤0.01% 1229
2025
Q2 		$1.19M Buy
102,042
+62
+0.1% +$563 ﹤0.01% 1299
2025
Q1 		$758K Sell
101,980
-6,546
-6% -$50.3K ﹤0.01% 1409
2024
Q4 		$651K Hold
108,526
– – ﹤0.01% 1448
2024
Q3 		$556K Buy
108,526
+3,323
+3% +$14.5K ﹤0.01% 1483
2024
Q2 		$381K Buy
105,203
+4,399
+4% +$14K ﹤0.01% 1578
2024
Q1 		$324K Sell
100,804
-48,892
-33% -$189K ﹤0.01% 1621
2023
Q4 		$734K Sell
149,696
-273,770
-65% -$1.25M ﹤0.01% 1373
2023
Q3 		$2.31M Sell
423,466
-131,311
-24% -$868K ﹤0.01% 1058
2023
Q2 		$3.72M Sell
554,777
-67,862
-11% -$505K ﹤0.01% 957
2023
Q1 		$5.5M Sell
622,639
-8,230
-1% -$72.6K 0.01% 855
2022
Q4 		$4.82M Buy
630,869
+53,210
+9% +$414K ﹤0.01% 872
2022
Q3 		$4.11M Buy
577,659
+59,103
+11% +$557K ﹤0.01% 926
2022
Q2 		$4.2M Sell
518,556
-749,517
-59% -$6.59M ﹤0.01% 938
2022
Q1 		$17.6M Sell
1,268,073
-734,571
-37% -$11.5M 0.01% 695
2021
Q4 		$56.1M Sell
2,002,644
-251,084
-11% -$7.7M 0.04% 450
2021
Q3 		$76.5M Buy
2,253,728
+51,843
+2% +$1.87M 0.07% 365
2021
Q2 		$89.8M Buy
2,201,885
+99,140
+5% +$3.85M 0.08% 330
2021
Q1 		$84.6M Buy
2,102,745
+93,441
+5% +$5.06M 0.08% 329
2020
Q4 		$119M Buy
2,009,304
+161,352
+9% +$8.32M 0.12% 243
2020
Q3 		$89.9M Buy
1,847,952
+124,605
+7% +$5.24M 0.11% 261
2020
Q2 		$83.4M Buy
1,723,347
+1,225,502
+246% +$44.7M 0.1% 268
2020
Q1 		$13.8M Buy
+497,845
New +$13.9M 0.02% 583

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Neuberger Berman Group's ADPT Position: Q1 2026 in Review

Neuberger Berman Group reduced its Adaptive Biotechnologies (ADPT) stake by 75% in Q1 2026, selling an estimated $5.43M and leaving 110,664 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Neuberger Berman Group first reported a position in ADPT in Q1 2020 and has held it in 25 quarters since. The position peaked at $119M in Q4 2020. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Neuberger Berman Group held 110,664 shares of Adaptive Biotechnologies worth $1.54M as of Q1 2026.
  • Neuberger Berman Group sold 340,905 Adaptive Biotechnologies shares in Q1 2026, an estimated $5.43M.
  • Adaptive Biotechnologies made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1264 holding.
  • Neuberger Berman Group first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 25 quarters since.
  • Neuberger Berman Group's Adaptive Biotechnologies position peaked at $119M in Q4 2020.
  • 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.